Wu Junnan, Xin Qilei, Wang Shuo, Zhang Xu, Jiang Chunping
Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.
Department of Hepatobiliary Surgery, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Front Microbiol. 2025 May 13;16:1531232. doi: 10.3389/fmicb.2025.1531232. eCollection 2025.
The aims of the present study were to determine the efficacy of edible traditional Chinese medicines (ETCMs) in treating constipation, verify their laxative effects, and conduct preliminary investigations into their mechanisms of action.
ICR mice were treated with loperamide to induce constipation, and various fecal parameters, including fecal volume, water content, and intestinal transport function, were measured in these constipation model mice to screen for ETCMs with laxative properties. The mechanism of action was preliminarily explored by examining changes in the intestinal mucosal structure, protein expression levels, and alterations in intestinal flora composition.
In ICR mice with loperamide-induced constipation, aqueous extract (ECAE) and aqueous extract (HDAE) significantly ameliorated constipation symptoms, mitigated colonic pathological tissue damage, significantly increased the expression levels of proteins associated with the promotion of intestinal peristalsis [Stem Cell Factor Receptor (c-Kit) and Stem Cell Factor (SCF)] and the maintenance of the intestinal barrier [Zonula Occludens-1 (ZO-l), Occludin and Claudin-l], and promoted beneficial intestinal bacterial colonization.
ECAE and HDAE ameliorated constipation in mice, and their mechanism of action may be related to the increased abundance of intestinal bacteria such as , and , which contribute to higher butyrate production. This increase in butyric acid reduces inflammation, improves intestinal barrier function, and increases the abundance of beneficial intestinal bacteria.
本研究旨在确定食用中药治疗便秘的疗效,验证其通便作用,并对其作用机制进行初步研究。
用洛哌丁胺处理ICR小鼠以诱导便秘,在这些便秘模型小鼠中测量各种粪便参数,包括粪便体积、含水量和肠道转运功能,以筛选具有通便特性的食用中药。通过检查肠黏膜结构变化、蛋白质表达水平和肠道菌群组成改变,初步探讨其作用机制。
在洛哌丁胺诱导便秘的ICR小鼠中,[具体中药1]水提取物(ECAE)和[具体中药2]水提取物(HDAE)显著改善便秘症状,减轻结肠病理组织损伤,显著提高与促进肠道蠕动相关的蛋白质[干细胞因子受体(c-Kit)和干细胞因子(SCF)]以及维持肠道屏障相关的蛋白质[闭合蛋白-1(ZO-1)、闭合蛋白和紧密连接蛋白-1]的表达水平,并促进有益肠道细菌定植。
ECAE和HDAE改善了小鼠便秘,其作用机制可能与[具体有益菌1]、[具体有益菌2]等肠道细菌丰度增加有关,这些细菌有助于产生更高水平的丁酸。丁酸的增加减轻炎症,改善肠道屏障功能,并增加有益肠道细菌的丰度。